- STAT+: OpenEvidence backs study that finds it beats LLMsIn this edition of STAT Health Tech: Dueling research pitting OpenEvidence against general purpose LLMs, use of Dexcom's CGM in children, and more.STAT · 18d ago↗ source
- Who’s going to run the FDA?RFK Jr.'s list of Covid vaccine injuries, a father's quest to cure his daughter, and more health news from Morning RoundsSTAT · 18d ago↗ source
- GSK walks away from Alector pact as immuno-neurology bet fizzlesAfter two high-profile trial failures over the past year, GSK is breaking off a deal that features $700 million upfront that it signed with Alector for neurodegenerative disease treatments. GSK’s…Endpoints · 18d ago↗ source